The aim of this study is to evaluate tDCS effects on schizophrenia symptoms, particularly on auditory verbal hallucinations. tDCS applied with cathodal (inhibitory) electrode over the left temporal parietal junction and anodal (excitatory) electrode over the left dorsolateral prefrontal cortex.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
3
repetitive daily tDCS sessions for a period of one week
Herzog Hospital
Jerusalem, Israel, Israel
change from baseline in auditory hallucination rating scale
Time frame: 1 week post-treatment
change in self-report quality of life scale from baseline
Time frame: 1 week post treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.